Intelligence coverage: 55%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
VBIO
Valion Bio, Inc.AI confidence 70% · prior close shown (market closed)
Investment Snapshot
Why it matters
Valion Bio, Inc. shows stable business momentum based on AlphaOS pipeline evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 0d ago
VBIO's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on VBIO.
Free accounts see more of this; Premium sees all of it.
Latest earnings · Q3 2025
Full VBIO earnings analysisReported figures for Valion Bio, Inc. — research only, not investment advice.
- Revenue YoY
- +15.9%
Latest Intelligence
Updated
What happened recently for Valion Bio, Inc. (VBIO) — events, not interpretation.
- Event
- Reported Q3 2025 revenue +16% YoY.
- Also
- Last session September 29, 2026 at $2.83.
- Source
- Q3 2025 earnings
Research & analysis only — not investment advice.
Building company intelligence…
Valion Bio, Inc. (VBIO)
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Valion Bio, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Key facts
- Market cap:
- $62.80M
- Revenue:
- $780,000
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected intelligence
Follow Valion Bio, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Related stock research
Connected companies and research pages from the AlphaOS knowledge graph.
- HUMANA INC (HUM)Investment Snapshot & knowledge graph →
- CANADIAN PACIFIC KANSAS CITY LTD/CN (CP)Investment Snapshot & knowledge graph →
- CAMECO CORP (CCJ)Investment Snapshot & knowledge graph →
- UNION PACIFIC CORP (UNP)Investment Snapshot & knowledge graph →
- CARDINAL HEALTH INC (CAH)Investment Snapshot & knowledge graph →
- PACCAR INC (PCAR)Investment Snapshot & knowledge graph →